Vesicles in Nature and the Laboratory:Elucidation of Their Biological Properties and Synthesis of Increasingly Complex Synthetic Vesicles by Fernandez-Trillo, Francisco et al.
 
 
University of Birmingham
Vesicles in Nature and the Laboratory
Fernandez-Trillo, Francisco; Grover, Liam M.; Stephenson-Brown, Alex; Harrison, Paul;
Mendes, Paula M.
DOI:
10.1002/anie.201607825
License:
None: All rights reserved
Document Version
Peer reviewed version
Citation for published version (Harvard):
Fernandez-Trillo, F, Grover, LM, Stephenson-Brown, A, Harrison, P & Mendes, PM 2017, 'Vesicles in Nature
and the Laboratory: Elucidation of Their Biological Properties and Synthesis of Increasingly Complex Synthetic
Vesicles', Angewandte Chemie (International Edition) , vol. 56, no. 12, pp. 203–229.
https://doi.org/10.1002/anie.201607825
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Angewandte
International Edition
A Journal of the Gesellschaft Deutscher Chemiker
www.angewandte.org
Chemie
Accepted Article
Title: Vesicles and their multiple facets: underpinning biological and
synthetic progress
Authors: Paula M. Mendes, Francisco Fernandez-Trillo, Liam Grover,
Alex Stephenson-Brown, and Paul Harrison
This manuscript has been accepted after peer review and appears as an
Accepted Article online prior to editing, proofing, and formal publication
of the final Version of Record (VoR). This work is currently citable by
using the Digital Object Identifier (DOI) given below. The VoR will be
published online in Early View as soon as possible and may be different
to this Accepted Article as a result of editing. Readers should obtain
the VoR from the journal website shown below when it is published
to ensure accuracy of information. The authors are responsible for the
content of this Accepted Article.
To be cited as: Angew. Chem. Int. Ed. 10.1002/anie.201607825
Angew. Chem. 10.1002/ange.201607825
Link to VoR: http://dx.doi.org/10.1002/anie.201607825
http://dx.doi.org/10.1002/ange.201607825
REVIEW          
 
 
 
 
 
Vesicles and their multiple facets: underpinning biological and 
synthetic progress 
Francisco Fernandez-Trillo,*[a] Liam M Grover,*[b] Alex Stephenson-Brown,[b] Paul Harrison,[c] Paula M 
Mendes,*[b]  
aSchool of Chemistry, bSchool of Chemical Engineering and cInstitute of Inflammation and Ageing (IIA), University of Birming-
ham, Edgbaston, Birmingham, B15 2TT, UK 
 
 
  
10.1002/anie.201607825Angewandte Chemie International Edition
This article is protected by copyright. All rights reserved.
REVIEW          
 
 
 
 
 
The important role of vesicles in many aspects of cell function is well 
recognized but only recently have sophisticated imaging techniques 
begun to reveal their ubiquity in nature. While we further our under-
standing of the biological properties of vesicles and their physiologi-
cal functions, increasingly elegantly designed artificial vesicles are 
being reported for a wide range of technological applications and 
basic studies. Herein, we bring together both the biological and 
synthetic state-of-the-art on vesicles and place their biological fea-
tures in the context of recent synthetic developments, providing a 
unique view of these complex and rapidly developing fields. The 
perspectives on the challenges and opportunities for future biological 
and synthetic progress on vesicles are also presented. 
1. Introduction 
While vesicles have been known to exist for more than 50 
years,[2, 3] it was in the early 1990s when we witnessed the 
breakneck pace of scientific advancements in vesicle biology. 
Recent innovation[9] in analytical techniques for imaging and 
detection of hydrated vesicular structures have tremendously 
expanded our understanding of how the chemical structure and 
function of vesicles contribute to biological roles as diverse as 
compartmentalization, storage and molecular trafficking. Vesicle 
trafficking is inextricably linked with processes of secretion (exo-
cytosis) and uptake (phagocytosis and endocytosis) and, among 
other functions, allows for transit of signaling molecules that 
mediate cellular communication.[12] In addition, vital roles in a 
wide variety of physiological and pathological processes are 
beginning to be recognized, ranging from signaling in the brain, 
regulation of immunity, coagulation, angiogenesis and cancer 
progression.[12, 13] Recent findings also indicate that signals shut-
tled by stem cell-derived extracellular vesicles (EV) may be 
critical in the maintenance of stemness or differentiation, as well 
as in stem cell-mediated tissue repair after injury.[17] 
The distinct and diverse range of vesicle functions is enabled 
by exquisite chemical and structural variation that ultimately 
allows for the guidance, release or deposition of their contents in 
a specific location intra- or extra-cellularly. It is this deeper un-
derstanding of their morphological, structural and biological 
characteristics that is providing us with the tantalizing possibility 
of tailoring structure/chemistry such that they may be used in a 
multitude of biological and non-biological applications. In parallel, 
our knowledge and expertise in synthetic, supramolecular, col-
loidal and biological chemistry has progressed significantly in 
recent years and as such our capacity to mimic nature’s ability to 
build sophisticated vesicular systems has improved. We can 
now build artificial vesicles that show some or many of the traits 
found in natural vesicles and cells, including membrane compo-
sitional heterogeneity, membrane recognition, and/or compart-
mentalization.  
Owing to the high complexity of biological systems, synthetic 
vesicles have served as highly valuable model systems for the 
analysis of diverse biophysical processes occurring at cell mem-
branes, including membrane permeability, cellular transport, 
endo- or exocytosis and fusion of membranes.[18, 19, 20] Addition-
ally, vesicles are being tailored to allow both targeted delivery 
and sustained release, and have been applied as vehicles for 
delivery of both hydrophobic drugs, which are incorporated into 
the membrane, and hydrophilic drugs, which are encapsulated in 
the interior aqueous compartment.[21, 22, 23] Furthermore, bottom-
up approaches are being actively pursued to engineering more 
complex vesicle-based systems and construct artificial minimal 
cells[24] that mimic functions of natural cells, including gene 
expression, membrane transport, subcellular localization and 
biochemical reactions. The minimal-cell model system is meant 
to represent the hypothetical precursor structures of early living 
cells in early evolution, creating new opportunities for insights 
into the origin of life.[25, 26] Concurrently, with recent advances in 
the construction of vesicle-based minimal cell analogues, inno-
vative platforms for biotechnology and biomedical applications 
are being introduced.  
While these two fields of research – biological vesicles and 
artificial vesicles – have much to contribute to each other, and 
despite the vast amount of progress in these areas, they are yet 
to be discussed together critically in a single review. It is there-
fore our aim in this review to bring together our knowledge of the 
specialized structure and function of diverse biological vesicles 
and the recent advances in the synthesis of vesicle systems 
from synthetic and biological building blocks. We will first de-
scribe our current understanding of biological vesicles, focussing 
on extracellular vesicles and their classification. Extracellular 
vesicles, similarly to most synthetic vesicles, are generated to 
function outside of the cell, laying out a common ground for joint 
discussion of their properties and functions. It is beyond the 
scope of this review to delve into the different aspects of intra-
cellular vesicles (i.e. peroxisomes and lysosomes) and the read-
er is directed to recent excellent reviews on the subject.[27, 28, 29] 
In the following sections, we discuss different properties of 
biological and synthetic vesicles, namely membrane composi-
tional heterogeneity, membrane binding and downstream events, 
compartmentalization, internalized chemical transformations and 
growth and self-replication. Besides providing insights into their 
functional importance in a biological setting, the discussion is 
also focussed on how such properties are achieved biologically 
and synthetically. Where applicable, we highlight how biological 
systems have inspired synthetic systems and how synthetic 
systems have been providing insights into structure and function 
of biological vesicles. A brief look at the current status and the 
future outlook of the biological and artificial vesicle field con-
cludes this review. 
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2. Extracellular vesicles 
Although it has been known that extracellular vesicles play an 
important role in the clotting of blood since the 1940’s [30] and in 
the controlled mineralization of bone since 1969,[31] until recently 
the scientific community had not appreciated the full breadth of 
processes in which extracellular vesicles were central. Vesicles 
have now been shown to mediate DNA, mRNA and microRNA 
transfer,[32, 33, 34] promote[35] and inhibit inflammatory 
processes,[36] mediate mineralization and facilitate para- and 
juxtacrine communication.[37, 38] Recent work has strongly implied 
that certain beneficial effects following stem cell treatment may 
occur as a consequence of the secretion of exosomes by mes-
enchymal stem cells.[39, 40] The prospect of harnessing the thera-
peutic benefits of mesenchymal stem cells without the risks of 
carcinogenesis and immunological response has generated a 
considerable amount of academic and commercial interest in 
these exosomes and other cell derived vesicles.[41] Given that 
such vesicles may be classified as medicines, there is now an 
important concerted effort between academics and industry alike, 
to characterize vesicular markers, properties and potency so 
that they may be translated into the clinic.  
Extracellular vesicles (EVs) also have enormous potential as 
biomarkers.[42, 43] Measurement of EVs within biological fluids 
provides a non-invasive “liquid biopsy” of health and disease. 
Changes in EV size, concentration, protein and RNA content 
have essentially been described in all major diseases (e.g. can-
cer, cardiovascular disease, autoimmunity and disorders of 
pregnancy).[42, 43] Biophysical approaches are now available for 
measuring EV, including the application of nanoparticle tracking 
analysis, dynamic light scattering and tunable resistive pulse 
sensing amongst others.[44] These allow accurate measurement 
of EV number and size distributions but are still limited in meas-
uring of phenotypes. 
Major challenges that remain in this area are their character-
ization and categorization of vesicles of biological origin.  At 
present, a surfeit of terms has been used to describe what are 
very similar structures with overlapping function, size and origins 
(endosome, exosome, microvesicle, ectosome, matrix vesicle, 
microparticle, shedding vesicles).[42, 45, 46]  
2.1. Vesicle classification 
With the growth of the research focused on EVs and a recent 
explosion in the literature, there has been a significant effort to 
harmonize the definition of the different forms of vesicles.[47] The 
current terminology and definitions associated with extracellular 
vesicles are given in Table 1. An important observation is that 
the size ranges for biogenic vesicles lies on a continuum and as 
such it is frequently extremely challenging to classify vesicle 
origin and function. 
 
Table 1. A summary of the properties of the three types of cell-derived 
vesicle with distinct biogenic origins. 
Vesicle type Size range  
(nm) 
Distinctive Features Origin 
Exosome 30-100 Presence of specific 
membrane recep-
tors: tetraspanins 
(CD9, CD63), Alix, 
flotillin-1 and 
Tsg101 
Derived from the 
ESCRT pathway 
and fusion of the 
MVB with the outer 
membrane 
Microvesicles 20-800 Comparatively high 
surface phospha-
tidyl-serine content 
Budded directly off 
the surface of the 
cell membrane 
Apoptotic 
vesicles/bodies 
500-2000 Can contain dense-
ly packed orga-
nelles and may 
contain DNA 
Blebbed from the 
surface of the cell 
membrane, often 
during apoptosis 
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Efforts are currently being made to identify markers that can 
facilitate the identification of EVs from different sources.[48] There 
is now a consensus emerging that there are three main classes 
of vesicle with differing membrane structure: Exosomes, micro-
vesicles and apoptotic vesicles. Each of these classes is distinct 
in the manner that they are formed, which leads to them having 
very distinct membrane properties and functions. Importantly, 
the identification of surface markers for these vesicles has al-
lowed for researchers to begin more systematically classifying 
these structures, which are found in a multitude of biological 
fluids. 
2.2. Exosomes 
Despite an overlap in diameter, microvesicles and exosomes 
have distinct markers and a clearly contrasting mechanism of 
biogenesis.  The formation of exosomes occurs through the 
ESCRT (Endothelial Sorting Complexes Required for Transport) 
pathway, whereby particles or macro-molecules pass through 
the cell membrane and are encapsulated within an early endo-
some.[49] The early endosome is marked by the ESCRT complex 
and migrates to an aggregation of vesicles found within the cell 
known as the Multi-Vesicular Body (MVB) (Figure 1).[50] The 
development of local heterogeneities within the membrane struc-
ture of the vesicle provokes deformation and invagination of the 
membrane and ultimately the formation of an interluminal vesicle 
(ILV).[51] The MVB is anchored to a network of micro-tubules 
within the cell on which the MVBs may be transported directly to 
a specific location.  The movement of these vesicles through the 
cell occurs via the molecular motors dynein and kinesin,[52] which 
are thought to facilitate the movement of the vesicles to the 
periphery of the nucleus or the cell membrane, respectively.  
The mechanism of movement and secretion, however, is signifi-
cantly more complex and many of its intricacies remain un-
known.  Researchers have, however, identified that levels of 
cholesterol within the vesicle correspond strongly to vesicular 
movement, with unconstrained concentration of cholesterol 
within the MVB preventing migration to the cell membrane.[53]  
The movement of the MVBs to the cell periphery are strongly 
associated with the Rab proteins and Rab27 has been shown to 
be critical to this process, but is not responsible for the fusion of 
the MVBs with the cell membrane.[54] Other Rab proteins have 
been found on the surface of recovered exosomes and as such 
are implicated with the membrane fusion process (Rab35 and 
Rab11).[55] Another family of proteins known as SNAREs en-
hance the association of the MVBs with the internal leaflet of the 
cell membrane (Figure 1).[56] A subsequent intracellular influx of 
calcium ions initiates fusion and the ILVs within the cell may be 
released into the extracellular fluid.  
Exosomes contain a population of membrane and cytosolic 
proteins, lipids and RNA that vary in part according to the cells 
from which they originate.[57] They are characterized by the 
presence of lipid rafts, which allow for sorting of raft-associated 
proteins, such as follitin and tetraspanins, and regulation of 
signaling processes. Exosome composition and organization 
enable them to play a pivotal role in cell to cell communication, 
particularly between the far distance cells in the body. Exo-
somes are not only responsible for triggering downstream sig-
naling but they also specifically target the recipient cells and 
deliver proteins and RNA to them.[57]  
2.3. Microvesicles 
Rather than being derived from the ECSRT, microvesicles bud 
directly from the cell membrane.  They are also known as micro-
particles, shedding vesicles, ectosomes and exovesicles.[42] 
They form following the influx of calcium ions into the cell, which 
causes the reorganization of the cell cytoskeleton and results in 
the formation of nanodomains within the cell membrane.  As 
they are derived directly from the cell membrane, these vesicles 
exhibit high concentrations of phosphatidyl-serine (PS) and 
cholesterol.  During the formation of the microvesicles,  
Figure 1. Exosomes are generated through the ESCRT (Endothelial Sorting 
Complexes Required for Transport) pathway. Briefly, vesicles are formed after 
the absorption of extracellular objects through the cell membrane. A) These 
vesicles are transported to a MVB (multivesicular body) and may then be 
transported to the nucleus or to the cell membrane, this movement is mediated 
by the molecular motors dynein and kinesin. B) At the membrane, Rab and 
SNARE proteins mediate attachment to the internal leaflet of the membrane, 
after which they merge with the membrane and release the exosomes into the 
extracellular space. 
flippase and scramblase activity is modified, which inverts the 
inner leaflet of the membrane and exposes PS.  The enzymes 
flippase, floppase and scramblase are actively involved in creat-
ing and maintaining asymmetry in the cell membrane by ena-
bling the movement of lipid molecules between the internal and 
external leaflets of the membranes.  Modifying the balance in 
molecular transport through the membrane reduces the stability 
of the cell membrane.  This, in addition to the action of calpain, 
which cleaves the attachment of the cytoskeleton to the mem-
brane cause the budding of vesicles from the cell membrane.  
During the formation of microvesicles, proteins from the cell 
membrane and within the cell are collected and released asso-
ciated with the microvesicles.[58, 59] Unlike exosomes, the com-
position of microvesicles is not so well characterized but their 
protein enrichment on cytokines, chemokines, matrix metallopro-
teinases and integrins have been reported.[61] Nevertheless, 
protein composition depends on cell type of origin. Microvesicles, 
in common with exosomes, are intracellular protein and RNA 
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transporters and share the capability to reprogram the recipient 
cell.[61] For instance, microvesicles are important carriers of 
cytokines and chemokines that can induce subsequent cell and 
tissue response, which can have a multitude of therapeutic or 
pathological effects.[46, 60] 
2.4. Apoptotic vesicles 
As shown in Table 1, apoptotic vesicles or apoptotic bodies may 
be considerably larger than exosomes or microvesicles.  Similar-
ly to microvesicles they form directly from the cell membrane 
during the process of apoptosis. In addition to cell membrane 
and cytosolic proteins, apoptotic vesicles contain DNA. They 
also exhibit exposed PS on the surface of the membrane and, in 
contrast to both microvesicles and exosomes, have a membrane 
of sufficient permeability to allow for staining of the intervesicular 
DNA using propidium iodide.  The predominant role of these 
vesicles is as yet unknown, but it has been hypothesized that 
they may be responsible for horizontal gene transfer between 
cells.[62]  
3.  Membrane compositional heterogeneity 
Lateral (heterogeneities at one leaflet of the membrane, termed 
lipid rafts) and transverse (different constituents on the inner and 
outer leaflets of the bilayer) asymmetry in cell membranes play 
key roles in many cellular events. Lipid rafts are dynamic submi-
croscopic assemblies, more ordered and tightly packed than the 
surrounding bilayer and involved in cellular processes such as 
adhesion, budding and signaling.[63, 64] Cell membranes are also 
characterized by transversal asymmetry with specific lipids en-
riched in the extracellular leaﬂet, whereas others, namely PS 
and phosphatidylethanolamine (PE) are primarily localized in the 
cytoplasmic leaflet. Transverse asymmetry, which is maintained 
by a family of membrane-bound transport proteins called phos-
pholipid translocases, is required for normal membrane function 
and disruption of this asymmetry is a biochemical feature in 
apoptosis, platelet activation and cell fusion.[65, 66]  
Membrane compositional heterogeneity have been also re-
ported in EVs, recognized to be related with the process of 
vesicle formation and expected to play a key role in trafficking 
and signaling, and thus in their regulatory mechanisms. The 
composition of EV membranes does not reflect that of the parent 
cell membrane but are enriched or depleted in particular lipids 
and proteins of their parent cells.[67] Exosomes, which have been 
the most studied by lipidomics, exhibit lipid raft-like domains. 
Exosome composition is enriched with lipids that are critical for 
the maintenance of rafts, such as cholesterol, sphingolipids, 
ceramide, and glycerophospholipids with long and saturated 
fatty-acyl chains.[68] Many raft-associated proteins are also pre-
sent in exosomes, including tetraspanins, GPI-anchored proteins, 
Src tyrosine kinases and proteins containing prohibitin do-
mains.[67, 69] Owing to the high content of raft-associated lipids 
and proteins and their organization, exosomal membranes ex-
hibit greater rigidity than cell plasma membranes. The rigidity is 
pH-dependent and increases from pH 5 to pH 7.[70] The elevated 
structural rigidity is anticipated to enhance the membrane fusion 
with the plasma membrane of recipient cells at physiological pH 
and prevent lipolytic or proteolytic degradation of exosomes 
while in circulation. It also accounts for their stability under vari-
ous storage conditions for up to 90 days.[71] 
EVs are also often typified by an increased rate of trans-
bilayer movements of phospholipids (i.e. flip-flop) as compared 
to the plasma membranes of parent cells.[70, 72] It can result in 
symmetry in lipid distribution between the two membrane leaflets 
and PS externalization, whereas its asymmetric distribution in 
the inner leaflet of plasma membrane is well established. The 
loss of asymmetry is likely due to the lack of translocase activity. 
While absence of lipid translocases has been reported,[73, 74] 
phospholipid asymmetry in some EVs is still achieved and might 
be explained by their interactions with cytosolic protein do-
mains.[74] EVs are diverse in composition and organization, and 
currently more studies are necessary to understand their struc-
ture and, indeed, its correlation with properties and function. It 
will ultimately, for instance, inform the formulation of specific and 
effective vesicle-based therapeutics, i.e. vesicles with specific 
target recognition, no cargo leakage, better stability and longer 
circulation times. 
While we further our understanding of how EVs display a 
large repertoire of biomolecules that affect their overall proper-
ties and functions, important progress has also been made in 
creating lateral and transversal heterogeneity in synthetic vesi-
cles. In artificial systems, lateral asymmetry has been achieved 
using mixtures of lipids with different phase transition tempera-
tures. This asymmetry results in phase separation and genera-
Figure 2. Schematic diagram of some of the reported strategies to generate asymmetric vesicles, namely enzymatic[1] and chemical[4]  modifications on the 
outer leaflet, outer leaflet lipid exchange using cyclodextrin derivatives,[5, 6] layer by layer assembly on emulsified water droplets[8] and microfluidic 
droplets,[11] pH gradient imposed across the membrane[14] and exchange using lipid transfer proteins, including removal of outer leaflet lipids.[15, 16]  
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tion of different lateral phases, including liquid disordered, liquid 
ordered and solid-like gel phases.[75] Lipid mixtures can therefore 
be developed that phase separate into two or more of these 
coexisting phase domains, creating lipid rafts.[76] In a study con-
ducted by Yanagisawa and co-workers,[77] lipid phase separation 
was explored in conjunction with differences in osmotic pressure 
to induce complex vesicle shape transformations that were 
followed by domain budding.  
Vesicles exhibiting Janus-like morphology have also been 
constructed in a way that allowed the local confinement of 
DNA.[78, 79]  Inspired by how membrane proteins are targeted to 
raft domains through palmitoylation (i.e. the post-translational 
addition of palmitic acid), Arbuzova and co-workers[79] were able 
to palmitoylate a DNA-recognizing peptide nucleic acid (PNA) 
with the aim of exclusively partitioning the PNA into the liquid-
ordered domains of liquid-liquid phase separated giant unilamel-
lar vesicles (GUVs). This strategy was highly effective, allowing 
the combination of specific partitioning of lipophilic DNA and 
PNA molecules into defined membrane environments with the 
reversible temperature-dependent intermixing of laterally sepa-
rated membrane domains.  
In contrast to the limited number of methods on how to 
achieve lateral asymmetry, a variety of strategies have been 
reported over the years to construct vesicles with transverse 
lipid asymmetry (Figure 2). It is noteworthy that these strategies 
are associated with various degrees of control of asymmetry and 
scope of components that can be used to achieve an asymmet-
ric bilayer. Early examples of synthetic asymmetric vesicles 
relied on enzymatic[1] and chemical[4] modifications of external 
lipids and the capability of lipid transfer proteins to promote lipid 
redistribution.[15, 16] Transmembrane pH gradients have also 
been exploited successfully to induce transverse asymmetry in 
vesicles partly composed of lipids bearing weak acid or weak 
base headgroups.[14] The properties of this amphiphilic system 
have been also fine-tuned to create compositional asymmetry in 
the two leaflets. Membrane-spanning bola-amphiphiles with two 
headgroups of different sizes have been reported to self-
assemble into asymmetric vesicles via steric effects.[80] In a 
conceptually similar fashion, amphiphilic asymmetric block co-
polymers can also be used to create vesicles with asymmetric 
membranes.[81, 82, 83] Taking ABC copolymers, where both outer 
blocks (A and C) are hydrophilic and the central (B) block hydro-
phobic, as an example, the chemical nature of the polymer 
chains expressed at the interior or exterior of the vesicle can be 
controlled by the relative size of the hydrophilic blocks. In gen-
eral, the longer amphiphilic block (A or C) is segregated to the 
exterior of the vesicle, while the shorter one is directed to the 
vesicle’s interior to minimize the interfacial tension and enhance 
the vesicle curvature.[82, 84] 
Recently, Kimura and co-workers have harnessed the prop-
erties of amphiphilic block polypeptides to construct peptide-
based asymmetric vesicles.[85] Key for achieving asymmetry was 
the use of right- and left-handed helical polypeptides, which 
were capable of forming a stereocomplex and could be arranged 
alternately in the vesicular membrane (Figure 3). Furthermore, 
dipole-dipole interactions between the hydrophobic helices 
allowed an interdigitated helix packing of the stereocomplex. 
Using this antiparallel arrangement and introducing steric effects, 
control over the molecular orientation of two host right- and left-
handed helical polypeptides was achieved. Further selective 
modification of either the outer or inner surface of the binary 
vesicle was possible by inclusion of a third guest helical poly-
peptide in the bilayer, in which the helix sense (right- or left-
handed) defined the orientation of the polypeptide in the mem-
brane. 
 
Figure 3. Schematic representation of a peptide-based asymmetric vesicle 
formed as a result of helix dipole, stereocomplex and steric effects. Modifica-
tion at the outer or inner surface can be performed by selecting either a right-
handed or left-handed helical peptide. 
Strategies have also been devised based on the ability of 
cyclodextrin (CD) derivatives to bind phospholipids and to ex-
change them with a pre-formed lipid bilayer.[5, 6] Here, asymmet-
ric vesicles are prepared by exposing unilamellar vesicles to a 
solution of cyclodextrin derivative loaded with the desired lipid 
species. Only the outer leaflet of the vesicle bilayer can directly 
exchange lipids and thus be enriched with the lipid previously in 
complex with the CD. This approach is especially appealing 
since it allows for the generation of asymmetry with a variety of 
lipid compositions and, as shown recently, incorporation of a 
highly controlled level of cholesterol in the asymmetric vesicle.[6] 
Rather than using exchange, lipid vesicles with highly con-
trolled asymmetry can be assembled in a step-by-step fashion. 
Microfluidic technologies, which are capable of efficiently gener-
ating monodisperse droplets, have been applied in the produc-
tion of asymmetric vesicles using a layer-by-layer assembly 
approach.[11] In another example involving such an assembly 
strategy, Weitz and co-workers[8] have reported a water-in-oil 
emulsion-based method wherein the inner monolayer is first 
formed via the emulsification of water droplets in oil containing 
the first amphiphile of interest. The outer leaflet is subsequently 
generated by forcing the emulsified water droplets through a 
second oil-water interface containing the second amphiphile 
using centrifugation. This method allows for encapsulation effi-
ciencies of almost 100%, addressing another common challenge 
when making synthetic vesicles.[86] This strategy has been 
adopted[87] to asymmetrically distribute PS at the outer leaflet of 
the vesicle to resemble apoptotic bodies and phosphatidic acid 
(PA) at the inner layer to enhance innate antimycobacterial 
activity in phagocytes while limiting the inflammatory response. 
These asymmetric apoptotic body-like vesicles provide a promis-
ing immunotherapeutic platform for Mycobacterium tuberculosis. 
In biological membranes, the final organization of proteins in 
lipid bilayers is mainly governed by three parameters – protein 
characteristics, the aqueous extra-membrane environment and 
lipid composition.[66, 88] The charge and specific hydrophilic and 
hydrophobic domains of the lipids directly influence the process-
es of insertion, folding and topology of proteins in the membrane. 
Nevertheless, the principles and detailed mechanisms of lipid-
dependent assembly and organization of membrane proteins are 
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still elusive. Reconstitution of membrane proteins into artificial 
vesicles is thus used to elucidate the mechanisms by which 
membrane proteins interact with lipids in native membranes.[89, 
90] However, there are technical challenges regarding effective 
control over protein orientation within a vesicle bilayer. Proteins 
should not be randomly distributed and should be integrated in a 
desired orientation. Inspired by the earlier work on the formation 
of asymmetric vesicles using water-in-oil emulsion-based meth-
od, Oiki and co-workers[90] have successfully reconstituted the 
membrane potassium channel KcsA with either an outside-out or 
inside-out orientation in giant unilamellar vesicles (Figure 4). 
The lipid composition of the inner and outer leaflets was varied 
in a systematic manner and shown to influence protein insertion 
capability and rate, as well as protein channel function. The 
addition of KcsA in either an intravesicular or extravesicular 
solution dictated location of the pH-sensitive cytoplasmic domain 
(CPD) inside or outside of the vesicle. Indeed, the mechanism 
underlying the direct KcsA insertion was shown to be governed 
by the hydrophilic CPD, which hardly traversed the hydrophobic 
core of the bilayer, and thus was retained in the aqueous phase 
to which the KcsA was added.  
By using in vitro reconstitution vesicle systems, researchers 
are unveiling new insights into the dynamic lipid-protein molecu-
lar interactions that can have important implications to the de-
velopment of therapeutic approaches for disorders in which 
lipids play an important role. Notwithstanding, the versatility of 
the strategies reported, which enable asymmetric tunability of 
the vesicle’s molecular properties, are still to be further explored 
and developed to aid in the challenging undertaking of under-
standing the role of lipid asymmetry in membrane structure and 
function. Synthetic asymmetric lipid-based vesicles also suffer 
from time-induced loss of asymmetry due to transverse diffusion 
(flip-flop). The current lifetime is in the order of hours to days, 
which is strongly dependent on the lipid structure[91], and thus 
strategies to prepare more stable artificial asymmetric vesicles 
will be desired. 
Figure 4. Schematic representation of the water-in-oil emulsion-based method 
used to obtain vesicles containing KcsA in either orientation. KcsA insertion 
into vesicles from (A) the inside and (B) outside, where the lipids of the outer 
leaflet are chemically different from those of the inner leaflet. 
4. Membrane binding and downstream events 
EVs bind with the plasma membrane of target cells by ligand-
receptor interactions, fusion or internalization.[92] The ligand-
receptor binding can be determined by several adhesion pro-
teins present in EVs, including integrins, intracellular adhesion 
molecule 1 (ICAM1), tetraspanins and galectins, which have 
been shown to interact with membrane receptors and induce 
adhesion-dependent intracellular signaling events in the target 
cells.[93]  
It is well recognized that rafts play an important role in signal 
transduction by containing different signaling proteins which may 
cluster or fuse upon agonist stimulation, resulting in downstream 
signaling. Transferrin receptors have been shown to be a raft 
component in exosomes that upon stimulation by crosslinking 
induce downstream signaling pathways of target cells by trigger-
ing mitogen-activated protein kinase (MAPK) activation.[94] Re-
ceptor-ligand interactions mediated by exosomes on target cells 
have been also shown to suppress key tumor cell recognition 
pathways.[95] 
In other cases, however, binding is followed by the direct fu-
sion of the vesicle with the plasma membrane of the target cell. 
This fusion results in the integration of the vesicle membrane 
proteins into the membrane of target cells and the release of 
their contents into the cytoplasm to activate downstream events 
in target cells. The mechanism of EV-cell fusion is not well un-
derstood, but may involve integrins for adhesion and tetraspan-
in-enriched microdomains to facilitate exosome fusion.[96, 97] 
EVs can also be internalized via receptor-mediated endocy-
tosis by either the clathrin-dependent[98] or the lipid raft-
dependent endocytic pathways.[99] Endocytic uptake can be 
followed by fusion with the endosomal membrane. Phagocytosis 
is also a means of exosome internalization. Because of an en-
richment of PS in the outer layer of EVs, multiple PS binding 
proteins on target cells, including  two members of the Tim (T-
cell immunoglobulin-containing and mucin-domain-containing 
molecule) family transmembrane proteins Tim1 and Tim4) can 
bind exosomes and trigger phagocytic uptake of EVs.[100]  
In synthetic vesicles, membrane binding and downstream 
events have been facilitated by supramolecular chemistry and its 
molecular recognition principles. Molecular recognition of small 
and large molecules at the surface of vesicles has been accom-
plished either by selective metal-ligand coordination, hydrogen 
bonding and host-guest interactions.[101] In particular, host-guest 
interactions have been highly successful in reorganizing and 
assembling molecular constituents into the vesicle membrane 
bilayer. For instance, unilamellar vesicles comprising amphiphilic 
- and -CD have been formed and exposed to a divalent ada-
mantyl guest to mimic receptor clustering through multivalent 
interactions.[102] The selective affinity of the adamantyl moiety for 
the -CD and the fluidity of the bilayer have led to the binding of 
the two adamantyl moieties to two -CD in the vesicle, thus 
enabling -CD clustering, in a similar fashion to clustering in 
clathrin-mediated endocytosis. Multivalent interactions have 
been also demonstrated to occur on vesicles formed using am-
phiphilic cucurbit[6]uril (CB[6]) derivatives.[103] Exposure of the 
vesicles to -mannose-substituted spermidine led to vesicles 
functionalized with -mannose moieties, which bound specifical-
ly to the lectin concanavalin A (Con A) in a multivalent manner. 
Through a variety of functionalizations, researchers have al-
so developed strategies to transform binding events occurring at 
the vesicle interface into a response (e.g. a change in fluores-
cence signal). These efforts, with potential sensing applications, 
typically rely on co-embedding the receptors and the fluorescent 
reporters in the vesicle bilayer.[104, 105, 106] Upon binding, receptor 
sites are spatially re-organized, thus affecting the optical proper-
ties of co-embedded reporters and triggering a change in the 
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vesicle emission properties. This strategy has been employed to 
create vesicular aptasensors for the detection of thrombin[106] 
and adenosine.[107] Molecular recognition and signal transduction 
processes at the surface of vesicles have also been harnessed 
to control enzymatic activity.[108]  
In addition to transducing signals at the outer surface of the 
vesicles, researchers also embarked on studies aimed at mim-
icking cellular aspects of signal transduction across vesicle lipid 
bilayers. External small-molecule triggers, which passively dif-
fuse into the vesicle interior, have been shown to reversibly 
control dynamic protein–ligand interactions in giant vesicles.[109] 
Through interior enzymatic conversion of two different small-
molecule substrates, increase or decrease in the interior pH 
occurs that allows modulation of the pH-sensitive interaction 
between a Ni-NTA ligand on the vesicle membrane and a His-
tagged protein in the lumen.  
In line with other mechanisms of transduction in cell mem-
branes, which require changes in the organization of membrane 
components and receptor clustering processes, vesicles have 
been devised to transmit binding information across their lipid 
bilayers. Examples include the use of two different unsymmet-
rical membrane-spanning transmitter units that in the presence 
of an external signal molecule can dimerize, bringing internal 
signaling groups into close proximity. In turn, this has led to the 
possibility of stimulating internal FRET effects,[110] inducing metal 
(i.e. Cu2+) complexation[111] and intramolecular reactions at the 
inner bilayer surface.[112, 113] Regarding the latter, Schrader and 
co-workers[113] have reported lithocholic acid-based transmem-
brane blocks functionalized with bisphosphonate dianions on 
one side for oligoamine-recognition and a pair of thiol nucleo-
phile and pyridine disulfide substrate for intravesicle SN2 dis-
placement on the other side (Figure 5). The induced proximity of 
two transmembrane molecules units to one another inside the 
fluidic membrane facilitated the SN2 attack of the thiol onto the 
pyridine disulfide, resulting in the instantaneous release of thi-
opyridine.  
Figure 5. Chemical structure of the membrane spanning-molecules and 
chemical scheme showing the sensing and signaling reaction in the lipid 
bilayer of vesicles.[113] Exposure of 200 nm vesicles to diethylenetriamine 
(DET) led to the formation of a double chelate complex with two bisphosphate 
units in the bilayer, leading to the release of thiopyridine. 
These systems still face challenges related to the correct orien-
tation of the transmembrane so that all receptor heads and 
reactive sites point away from the outer and inner bilayer surface, 
respectively. Furthermore, systems should be devised that lead 
only to the formation of heterodimers and not to the assembly of 
two homodimeric entities. In spite of the vast importance of 
transmembrane signaling in nature, there is a paucity of pub-
lished work in the design and assembly of artificial signal trans-
duction vesicles. Consequently, future research in this area 
should be undertaken in order to build vesicle models that more 
closely reflect the complexity of signal transduction processes at 
natural cell membranes. 
Dynamic molecular interactions and rearrangement within 
vesicle bilayers have been also of considerable interest to un-
derstand the fundamental physical rules governing vesicle fusion. 
Membrane fusion is a ubiquitous and critical event in all living 
organisms, being the basis of many transmembrane transport 
processes, such as synaptic neurotransmission, endocytosis 
and exocytosis. The development of vesicle constructs that are 
able to control and direct the fusion of membranes will not only 
contribute to a better understanding of how fusion is naturally 
occurring, but will also open up new opportunities in the fields of 
materials science and the design of drug and gene transfection 
delivery tools.[114, 115] In vivo membrane fusion is a highly con-
trolled process. To mimic this process Hook and co-workers[116] 
exploited the hybridization of membrane-anchored DNA strands 
to selectively fuse lipid vesicles (Figure 6). To this end, DNA 
strands, which were partially duplexed, were modified with cho-
lesterol to ensure spontaneous incorporation into the lipid bilayer 
of the vesicles. The orientation of the DNA strands with respect 
to the cholesterol anchor was designed such that hybridization 
occurred in a zipper-like fashion, only bringing vesicles with 
complementary DNA sequences into close proximity. This strat-
egy triggered the fusion of the vesicles in a manner that resem-
bles the mode of action of the complex SNARE fusion proteins 
during native fusion.[56]  
Figure 6. Vesicle fusion mediated by DNA hybridization. Initially, vesicles were 
modified with the cholesterol-terminated DNA strands ds-1/4 and ds-2/3 (left 
side). As ds-1/4 and ds-2/3 encounter each other, they hybridized in a zipper-
like fashion, thus forming blunt-ended duplexes with 27 base pairs (ds-1/2) 
and 12 base pairs (ds-3/4) (middle). In this geometry, the bilayers were 
brought in contact with each other, leading to opening of the fusion pore (right 
side).[116] 
Fusion of vesicles by molecular recognition has been also 
achieved using metal coordination,[117, 118] host-guest interac-
tions,[119] and coiled coil peptide interactions.[120] For example, 
Richard and co-workers[118]  demonstrated the fusion of vesicles 
by the selective recognition between specific metal ions and 
vesicles bearing bipyridine ligands. Other model systems for 
membrane fusion have been constructed based on the selective 
recognition between boronic acids and cys-diols[121] and com-
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plementary coiled-coil-forming peptides.[120]  In the latter, one of 
the peptides was non-covalently decorated in cyclodextrin-based 
vesicles while the complementary was incorporated into phos-
pholipid vesicles using a cholesterol anchor. These investiga-
tions provide new insights into the complex chain of events of 
protein-induced membrane fusion, highlighting the importance of 
vesicle proximity and force transmission in membrane fusion. 
Fusion between vesicles opens up the possibility to add and mix 
the contents of different vesicles as will be discussed in the 
following sections.  
5. Vesicle compartmentalization 
One of the key roles of lipidic membranes in natural systems is 
to separate vital components into different compartments where 
they can be stored and protected (e.g. genetic information within 
the nucleus); trafficked within (e.g. endosomes) and outside (e.g. 
exosomes) cellular environments; or where functionality can be 
centralized (e.g. protein manufacture within the endoplasmic 
reticulum). This exquisite level of organization has been an 
inspiration for researchers to develop novel vesicle within vesicle 
systems that can find applications in drug delivery, sensing or as 
microreactors.[122, 123, 124] 
In natural systems, compartmentalization is a tightly regulat-
ed process where the creation of new compartments such as 
endosomes, lysosomes or multivesicular bodies is controlled by 
membrane receptors, signaling networks and structural proteins. 
For instance, uptake of nutrients, toxins and pathogens into 
endosomes and lysosomes is regulated by the endocytosis 
pathway.[125, 126] Binding at the cell surface dictates which of the 
alternate pathways (e.g. calthrin vs caveolin-mediated) will be 
employed. This binding then results in structural changes in the 
membrane and cellular components, including changes to lipid 
composition and recruitment of structural proteins, which then 
lead to membrane budding and the formation of new vesicles 
within the cell.[127, 128] 
 
Figure 7. Strategies commonly employed to prepare compartmentalized 
vesicles. A) Compartments are generated by invagination of vesicles from 
heterogeneities generated in the membrane. B) SUV are encapsulated inside 
a newly formed vesicle. The latter process if often facilitated by membrane 
binding or the use of microfluidics. 
While reproducing all of these features in a synthetic system 
is currently out of reach, researchers have often mimicked some 
of this machinery in order to drive compartmentalization in syn-
thetic vesicles (Figure 7). For example, heterogeneities in 
membrane composition, or changes in the chemical environment 
at the membrane interface, can be exploited to trigger the de-
formation of vesicles and the formation of novel compartments. 
For instance, the membrane of GUVs is normally destabilized 
under stress (e.g. osmotic shock or treatment with a surfactant) 
forming asymmetric vesicles.[129] Budding of the surface can then 
occur and lead to invagination of smaller vesicles, in a process 
analogous to the formation of ILVs in natural systems. Takagi 
and co-workers[130] demonstrated that the presence of raft do-
mains in these GUVs controls invagination, with the size and 
distribution of these domains having an important effect on the 
overall process. When raft domains were “evenly” distributed, 
they would curve inward to eventually become an invaginated 
vesicle. The size of the enclosed vesicles depended on the raft 
domain size, with smaller domains budding first, followed by 
mid-sized domains. Large raft domains however produced mon-
odisperse endocytic vesicles with multiple vesicles budding from 
the boundary. Okomura and co-workers have recently used a 
similar strategy for the compartmentalization of GUV prepared 
by electroformation.[131] 
As a result of this process, synthetic invaginated vesicles 
have very similar membrane compositions than the GUVs they 
originated from. However, this can be a limiting factor that pre-
vents researchers from exploiting differences in membrane 
composition in these compartments. In this regard, Vogel and 
co-workers demonstrated that the use of different lipid formula-
tions in each compartment, with different melting points (dipal-
mitoyl ∼ 41 ºC vs dimyristoyl ∼ 23 ºC vs dioleoyl ∼ -18 ºC) ena-
bles sequential release of the contents within the compart-
mentalized vesicle, something that can be of benefit in the appli-
cation of these synthetic vesicles (Figure 8).[132, 133] In this case, 
vesicles were prepared by a film-hydration protocol that enabled 
co-encapsulation of small unilamellar vesicles (SUVs) with dif-
ferent membrane composition. 
Figure 8. Schematic representation of consecutive enzymatic reactions in 
compartmentalized vesicles. The external nanoreactor surface carries biotin 
for immobilization on a neutravidin-coated glass slide. An increase of tempera-
ture triggers the release of the substrates in two distinct, consecutive steps at 
the two corresponding phase-transition temperatures, ∼ 23 ºC and then ∼ 41 
oC. After release from the SUVs, the substrates remain confined in the nano-
reactor, where they are converted by the enzyme to their particular fluorescent 
products.[132]  
Alternatively, researchers have employed molecular recogni-
tion between complementary bilayers to control compartmentali-
zation. This approach, which mimics the binding events that 
mediate vesicle formation in natural systems and how these 
vesicles are then trafficked, was early illustrated by the group of 
Zasadzinski with the encapsulation of SUVs inside large 
unilammelar vesicles (LUVs) formed upon unrolling of phospha-
tidylserine cochleate cylinders (Figure 9).[134] SUVs and cochle-
ate cylinders were functionalized with biotin to enable compart-
mentalization by ligand-receptor binding at the SUV-LUV inter-
face. Addition of sub-stoichiometric streptavidin facilitated SUV 
aggregation, while ensuring that enough biotin moieties were still 
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available. Cochleate cylinders on the other hand were saturated 
with streptavidin, allowing that the biotin-functionalized SUV-
clusters and streptavidin-functionalized cochleates interacted 
and formed compartmentalized vesicles, coined vesosomes by 
the authors. At the time, this strategy presented several chal-
lenges such as poor encapsulation efficiency (5-15% of the SUV 
encapsulated) and purity, with a mixture of LUVs, vesosomes, 
free aggregates and free vesicles being formed. Some of these 
challenges have now been addressed using alternative encap-
sulation protocols,[135] or purification steps (i.e. centrifugation, 
sedimentation).[136] 
Figure 9. Schematic representation of the synthesis of compartmentalized 
vesicles reported by Zasadzinski and co-workers.[134] 
Preserving the integrity of vesicles, while a secondary mem-
brane is being formed, is a key aspect in compartmentalization 
that is normally achieved by a careful choice of membrane com-
position. All in all, fusion of the formed compartments must be 
avoided. In this regard, Paleos and co-workers have carefully 
evaluated the effect of membrane composition and particle size 
over vesicle fusion and compartmentalization.[123, 137] Taking 
advantage of the supramolecular interaction between guanidini-
um and phosphate moieties to trigger vesicle binding, the au-
thors demonstrated that several events can occur upon binding, 
namely adhesion, fusion (Figure 10, top) and/or compartmental-
ization (Figure 10, bottom). For instance, addition of cholesterol 
increased the membrane fluidity and facilitated interfacial recog-
nition and fusion. Interestingly, vesicle adhesion and fusion 
occurred through mixing of the lipids but without leakage of the 
vesicle content. It was proposed that adhesion of LUVs to GUVs 
is the key step in the formation of compartmentalized vesicles, 
where LUVs are engulfed by the GUV, in a process similar to 
cell endocytosis (Figure 10). 
Figure 10. Mechanistic scheme for the formation of multicompartment vesicles. 
Step I: Fusion, Step II: Growth and Step II: Engulfment.[123] 
Parallel to this progress in vesicle synthesis and design, re-
cent advances in automation and microfluidics[138, 139] are allow-
ing researchers to design compartmentalized vesicular systems 
with narrow size distributions and excellent control over the 
number of compartments.[7] Here, monodisperse GUVs were 
prepared first using a microfluidic double emulsion technique.[140] 
These GUVs were then subjected to a second microfluidic dou-
ble emulsion process to yield the desired compartmentalized 
polymersomes. The amount of vesicles encapsulated (up to 3) 
was controlled by the diameter of the injecting capillary tube and 
GUV containing different dyes could be co-encapsulated using 
this technique (Figure 11, Left).  
Figure 11. A) Schematic illustration of the microfluidic device to prepare polymersomes containing several inner polymersomes and B-D) confocal microscope 
images.[7] E) Schematic illustration of the microfluidic device to prepare asymmetric compartmentalized polymersome and F-H) confocal microscope 
images.[10] 
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Similarly, our current understanding of membrane chemistry, 
and vesicle binding and fusion, is allowing researchers to pro-
duce non-spherical compartmentalized vesicles with excellent 
precision.[10] In this case, GUVs were encapsulated within an oil 
droplet and the organic phase allowed to evaporate to induce 
vesicle adhesion, fusion of the membranes and the formation of 
compartmentalized vesicles. Again, the use of microfluidics 
provided the precise control needed and vesicles with up to 10 
compartments could be prepared. Moreover, the use of two 
inner fluids in the injector tube facilitated the formation of aniso-
tropic/asymmetric vesicles that encapsulated different solutes 
within different compartments (Figure 11, right). 
These examples highlight how researchers are now capital-
ising on our understanding of lipid chemistry and physics, to 
design complex compartmentalized vesicular systems. These 
compartmentalized vesicles will not only improve the release 
kinetics of drugs,[139, 141] but will allow us to confine complex 
chemical transformations to vesicular systems, in an attempt to 
improve current chemical process, but also imitate some of the 
features observed in natural cells. Further discussion of these 
aspects is provided in the next sections. 
6. Chemical nanoreactors 
While there are no reports of the synthetic capability in EVs, 
researchers have been attracted for decades by the possibility of 
carrying out chemical transformations within the confined space 
of a vesicle.[142] Like in cellular systems, reaction rate is often 
increased due to concentration effects inside the bilayer, ion 
distribution at the vesicular interface or enhanced reactivity 
inside the vesicle.[143] More importantly, location of substrates, 
catalysts and/or products is restricted to the vesicle, a feature 
that nature constantly exploits to either protect valuable products 
(e.g. nucleic acids in the nucleus) or confine harsh conditions in 
localized compartments (e.g. enzymatic degradation in the lyso-
somes). In a similar fashion, researchers have now encapsulat-
ed enzymes and nucleic acids in synthetic vesicles where they 
can be protected from degradation and quite often stabilized due 
to macromolecular crowding[144] or stabilization at hydrophobic 
regions.[145] The potential of imitating natural systems using 
synthetic vesicles was first reported by Nolte and co-workers in 
1986.[146] In this system, the oxidation of simple alkenes was 
catalyzed by a synthetic model of cytochrome P-450. To function, 
the synthetic model required a membrane bound manganese 
porphyrin coupled to an axial ligand (N-methylimidazole), an 
electron donor (colloidal Pt) and an electron carrier (methylene 
blue), thus mimicking all of the features of the natural system. 
This biomimetic nanoreactor was able to reduce MnIII to MnII and 
produce the desired epoxides only in the presence of all of these 
components. 
The trade-off between vesicle stability and membrane per-
meability is possibly the biggest challenge when designing ve-
sicular reactors. Vesicle membrane has to be permeable to the 
reagents and products, while containing the catalytic species. In 
cellular systems, permeability is dictated by the composition of 
the membrane – that controls the passive diffusion of “small” 
solutes, and the presence of channels and pores – that regulate 
the, often active, transport of larger solutes.[147] Permeability in 
synthetic systems though is often dictated only by the choice of 
membrane components, which control the physical properties of 
the membrane, including the viscosity and crystallinity of the 
bilayer.[148, 149, 150, 151] Like in natural membranes, cholesterol is 
often inserted in lipidic membranes to increase their toughness 
while maintaining their elasticity, so that stable membranes with 
“controlled” permeability can be prepared. However, increasing 
membrane permeability can eventually result in higher vesicle 
instability, as illustrated by the destabilization of model lipidic 
membranes at “high” content of cholesterol.[152, 153] The stability 
of synthetic vesicles is further affected when used in complex 
media, such as that found in biological applications. Absorption 
of proteins and other biomolecules can result in lysis of the 
membrane and opsonization and uptake by macrophages for in-
vivo applications.[154] Coating vesicles with large “hydrophilic” 
polymers such as poly(ethylene glycol) (PEG) can increase the 
steric hindrance around the vesicles, thus minimising adsorption 
of biomolecules and increasing the stability (and lifetime) of the 
vesicles.[154, 155, 156] However, this steric hindrance also compro-
mises the diffusion of solutes across the membrane. Overall, 
long-term stability of the vesicle is highly desired when consider-
ing applications and it is not surprising that most of the research 
in this area has focused on the application of polymersomes in 
the synthesis of vesicular reactors.[142, 157, 158, 159] Polymeric am-
phiphiles have bigger dimensions than lipids and polymersome 
membranes can be up to 5 times thicker than lipidic ones.[160, 161] 
This increased thickness and the tendency of polymer chains to 
entangle make polymersomes less likely to break apart. Howev-
er, the diffusion of solutes through the polymersome membrane 
is compromised and makes most polymersomes impermeable to 
small molecules, with only a handful of polymersomes showing 
intrinsic permeability.[162, 163, 164]  
Researchers have exploited several strategies to improve 
the permeability of polymersomes.[165] One of the most effective 
approaches is exploiting natural membrane channels, which can 
be reconstituted in synthetic vesicles to produce pores of well-
defined sizes. This technology was first introduced by Meier and 
co-workers using poly(2-methyloxazoline)-b-
poly(dimethylsiloxane)-b-poly(2-methyloxazoline) PMOXA-
PDMS-PMOXA polymersomes that were permeabilized using a 
bacterial porin (OmpF).[166] These polymersomes were permea-
ble to small molecules such as ampicillin and encapsulation of a 
β-lactamase enabled the transformation of ampicillin to ampicilli-
noic acid within the aqueous lumen. In the absence of OmpF, no 
reaction was observed while encapsulation had a minor effect 
on the kinetics of the transformation. This strategy has been 
widely used and there are now examples of nanoreactors, which 
incorporate OmpF and other protein channels,[158, 159] to produce 
permeable polymersomes with applications in drug delivery,[167] 
as antioxidants[168] or in enzyme replacement therapy.[169] 
In recent years, not only single components but whole ma-
chineries have been encapsulated within synthetic vesicles, in 
an attempt to engineer nanoreactors that imitate some of the 
characteristics of natural cells. For example, the group of Lib-
chaber was able to encapsulate an Escherichia coli extract that 
contained all of the components needed for the transcription–
translation of encapsulated plasmids, including amino-acids, 
ribonucleotides, ribosomes, tRNA and T7 RNA polymerase.[170] 
The authors relied on a water-in-oil emulsion-based preparation 
to maximize the amount of extract encapsulated. A α-hemolysin-
eGFP fusion protein was then engineered, so that upon expres-
sion inside the vesicle, α-hemolysin would assemble into the 
membrane-active heptamer forming pores of 1.4 nm in diameter. 
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Efficient pore production during the first hours of the experiment 
ensured that nutrients were allowed to diffuse inside the vesicles 
to avoid exhaustion of the amino acids and nucleotides initially 
encapsulated, so that protein production could be maintained for 
more than four days. 
While a lot of research has been focused in “borrowing” 
components from natural systems, having access to the arsenal 
provided by synthetic chemistry opens up the path to alternative 
strategies for membrane permeability. For instance, incorporat-
ing stimuli-responsive materials can facilitate transport in vesi-
cles and nanoreactors, because changes in external conditions 
can trigger changes in their solubility and facilitate the diffusion 
of molecules across the membrane.[157] For example,  van Hest 
and co-workers exploited this principle for the synthesis of glu-
cose-responsive nanoreactors with controllable permeability.[171] 
In this case, poly(ethylene glycol)-b-poly(styrene boronic acid) 
(PEG-b-PSBA) was blended with poly(ethylene glycol)-b-
poly(styrene). The PEG-b-PSBA was selectively dissolved in the 
presence of glucose (or at high pH) creating pores in the mem-
brane of the nanoreactors. The activity of CalB encapsulated in 
the lumen of these polymersomes was shown to increase after 
removal of the PEG-b-PSBA blocks. No esterase activity was 
observed in the filtrate of purified “opened” nanoreactors, sug-
gesting that CalB was retained within the polymeric vesicles. 
Other stimuli such as pH,[172, 173] CO2[174] and UV[175] have been 
also exploited by other groups to increase the permeability of 
nanoreactors. 
In natural systems, location of enzymes is not restricted to 
the aqueous lumen and chemical transformations occur both at 
the membrane, inside the vesicular system and at the interface. 
This has inspired researchers to develop nanoreactors that can 
not only encapsulate active enzymes in the hydrophobic mem-
brane,[176, 177] but implement cascade reactions by colocalization 
of more than one enzyme within the same vesicular system. 
Enzymes can thus be located at the membrane surface, within 
the membrane or inside the vesicle to facilitate the sequential 
reaction of the products formed. A catalytic system composed of 
3 enzymes - CalB, horseradish peroxidase (HRP) and glucose 
oxidase (GOX) – was the first demonstrating the potential of this 
approach (Figure 12A).[178, 179] HRP was encapsulated in the 
vesicle membrane following co-liophilization with the polymeric 
amphiphile, dissolution in THF of this polymer-enzyme mixture 
and addition to an aqueous solution. GOX dissolved in this 
second aqueous solution was selectively encapsulated in the 
aqueous lumen. CalB in solution (outside of the polymersomes) 
hydrolyzed 1,2,3,4-tetra-O-acetyl-b-glucopyranose to form glu-
cose that was then oxidized by the GOX encapsulated in the 
aqueous lumen forming hydrogen peroxide as a by-product. This 
hydrogen peroxide was finally used by the HRP in the mem-
brane to oxidize 2,2’-azinobis(3-ethyl-benzothiazoline-6-sulfonic 
acid (ABTS), giving the coloured compound that allowed moni-
toring of the whole cascade. These catalytic systems normally 
result in an increase in the enzyme half-life, and in this particular 
case, the reported cascade was able to work for over 24 h, three 
times longer than when the enzymes were colocated free in 
solution. Alternatively, the same authors have demonstrated that 
CalB could be encapsulated in the membrane while HRP was 
covalently attached to the surface of the polymersome, with 
similar catalytic results (Figure 12B).[179] 
Figure 12. A) and B) Cascade nanoreactors exploiting the intrinsic potential of 
vesicles to segregate cargo.[178, 179] C) and D) Cascade nanoreactor based on 
additional vesicular compartments.[180] 
Recent developments in the synthesis of compartmentalized 
vesicles are allowing researchers to prepare vesicle within vesi-
cle nanoreactors that can also encapsulate cascade 
reactions.[180] In this case, SUVs formed from poly(styrene)-
block-[3-(isocyano-L-alanyl-amino-ethyl)-thiophene] (PSt-PIAT) 
were used to encapsulate two sets of enzymes: CalB or alcohol 
dehydrogenase (ADH). These enzyme-loaded polymersomes 
were then co-encapsulated within polybutadiene-b-poly(ethylene 
oxide) GUVs together with a fusion protein of phenylacetone 
monooxygenase (PAMO) and nicotinamide adenine dinucleotide 
phosphate (NADPH), and pro-fluorescent 7-((4-oxopentyl)oxy)-
3H-phenoxazin-3-one (Figure 12C). Encapsulation protected 
the enzymes from degradation by proteases while having a 
minor effect over the enzymatic activity. This system mimics 
compartmentalization within eukaryotic cells and highlights the 
potential of vesicles in synthetic biology and biotechnology. 
Other cascade reactors have been reported,[181, 182] some of 
which have applications for cofactor regeneration,[183] as antioxi-
dants[180, 184] or as antimicrobials.[185] This ability to carry complex 
chemical transformations inside vesicles has encouraged re-
searchers to use nanoreactors as artificial organelles that repro-
duce cellular behaviour, restore function to damaged cells or 
even improve their performance.[159, 186, 187] The incorporation of 
nanoreactors into cells was first demonstrated by Hunziker and 
co-workers with the internalization of trypsin loaded polymer 
vesicles by THP-1 macrophages.[188] PolyG oligonucleotides on 
the surface of PMOXA-PDMS-PMOXA polymersomes promoted 
recognition by macrophages and internalization, and trypsin-
loaded polymersomes remained active once internalized. 
Further developments in this area have resulted in the im-
plementation of cascade reactions within artificial organelles. 
Towards this end, Moore and co-workers reported a liposomal 
reactor that incorporated both the F0F1-ATP synthase motor 
protein and the photoinduced proton pump carotene-porphyrin-
naphtoquinone (C-F-Q) in its membrane.[189] Liposomes were 
prepared by the Biobeads method,[190] which ensured that F0F1-
ATP synthase was reconstituted with the right orientation. An 
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inward flow of protons was established upon irradiation of the C-
F-Q triad, protons that were required to activate the F0F1-ATP 
synthase motor. Overall, the organelle was able to produce ATP, 
the key intermediate in the intracellular transfer of energy 
(Figure 13A). Ensuring that the protein channel has the correct 
orientation is key in this synthesis, and formulations that result in 
an statistical orientation of this channel can have a detrimental 
effect in the performance of these artificial organelles.[191] 
Figure 13. Schematic of artificial organelles incorporating F0F1-ATP synthase 
and (A) C-P-Q proton pump [189] or (B) bacteriorhodopsin,[191] or (C) a cascade 
reaction within the vesicle lumen.[168] 
Cascade reactions in synthetic organelles can be also im-
plemented by co-encapsulation of enzymes in the aqueous 
lumen, an option that eliminates the drawbacks associated with 
the lack of control over the orientation of membrane channels. 
This strategy has been demonstrated with the internalization by 
THP-1 cells of polymersomes loaded with superoxide dismutase 
(SOD) and lactoperoxidase (LPO).[168] These nanoreactors re-
tained their activity within the cells and were able to work as 
antioxidants, allowing the in situ detection and detoxification of 
intracellular reactive oxygen species (Figure 13C). Interestingly, 
these polymersomes carried the channel protein OmpF to facili-
tate the diffusion of LPO substrates/products across the mem-
brane and increase the activity of these nanoreactors. 
Altogether, the increasing control over the positional assem-
bly of enzymes and catalysts, and the ability to facilitate diffusion 
of reagents and products across membranes, is enabling re-
searchers to implement complex multistep chemical transfor-
mations within vesicular systems. This is allowing researchers to 
now close the cycle and feedback to biological research, with 
the development of artificial nanoreactors that can impact biolog-
ical systems. These sophisticated nanoreactors should not only 
be able to reproduce and repair cellular behaviour, but eventual-
ly imitate all of the characteristics of natural systems.  
7. Artificial Minimal Cells 
The development of artificial minimal cells is possibly the ulti-
mate challenge in the synthesis and application of vesicular 
systems. Natural cells incorporate all of the features described 
above, including membrane asymmetry, functional compart-
ments and the ability to carry complex chemical transformations. 
Not surprisingly, implementing most (if not all) of these charac-
teristics in a single synthetic system has fascinated researchers 
for decades.[192, 193, 194] In particular, research in this area has 
focused in developing  vesicular systems that go beyond the 
simple imitation of biological processes,[195] but can grow and 
self-replicate.[194]  
This ability of synthetic liposomes to self-replicate was first 
reported by Luisi’s group, using an enzymatic cascade to facili-
tate the synthesis of phosphatidylcholine derivatives within soy-
bean phosphatidylcholine liposomes.[196] A further level of com-
plexity was then reported, where the encapsulation of a phos-
phorylase (PNPase) within oleic acid/oleate vesicles enabled the 
polymerization of ADP within the vesicles - a process that mod-
elled a cellular metabolism.[197] Autocatalytic hydrolysis of exog-
enous oleic anhydride in the aqueous lumen facilitated growth 
and self-reproduction of these vesicles,[198] constituting the first 
fully synthetic system capable of containing a metabolism while 
at the same time growing and self-reproducing. 
A common limitation when developing synthetic cells is to 
control the permeability of the membrane to facilitate diffusion of 
the “nutrients” while containing the machinery needed for the 
replication/templation of the genetic information. Nature uses a 
sophisticated network of membrane channels, organelles and 
compartments, and tightly regulates trafficking of these compo-
nents to facilitate transport of “nutrients” and products. Re-
searchers however do not have access to this degree of control 
and have relied alternatively on optimising membrane composi-
tion and properties. For instance, Szostak and co-workers postu-
lated that small fatty acids and their derivatives could increase 
the permeability of protocells.[199] In their approach, myristoleic 
acid and decanoic acid vesicles showed significantly higher 
permeability than phospholipidic vesicles to a range of model 
substrates, including ribose and nucleotides. Permeability was 
increased when “defects” were introduced in the membrane, 
blending fatty acids with other lipids (e.g. glycerol monoester of 
decanoic acid). However, charged nucleotides were not able to 
diffuse through the membrane on their own, limiting the applica-
tion of these vesicles. Conversely, imidazole-activated nucleo-
tides were able to diffuse through these fatty acid vesicles, ena-
bling the non-enzymatic replication of a DNA oligonucleotide 
inside the vesicles. This strategy can potentially be coupled with 
the controlled growth and replication of fatty acid vesicles, when 
fed with fatty acid micelles,[200] for the development of prebiotic 
models of cells. 
Ensuring that cellular content is equally distributed between 
the daughter cells is another challenge when developing syn-
thetic cells. Again, in nature this process is tightly regulated by a 
complex network of signals and scaffolds that can distribute 
cellular components into the dividing cells. In synthetic systems, 
as the system becomes more sophisticated, it is less likely that 
the replicating cells will maintain all of the original components 
and thus the replicating cellular systems quickly become non-
functional. Sugawara and co-workers addressed this limitation 
linking the process of self-replication of the information with the 
self-reproduction of the vesicle compartment.[201] In their ap-
proach, DNA was amplified inside a model vesicle using PCR 
(Figure 14). Cleavage at the membrane interface of an imine 
bond in a cationic membrane precursor triggered the formation 
of membrane components, vesicle growth and self-reproduction. 
More importantly, self-reproduction increased the cationic con-
tent of the growing vesicles, so that amplified DNA was able to 
associate with the growing membrane. Accumulation of cationic 
amphiphiles around amplified DNA eventually created an imbal-
ance in the membrane composition that lead to pre-organization 
and budding/deformation of these protocells. While this strategy 
is not perfect, and there are still issues such as maintaining the 
concentration of non-reproducing neutral and anionic lipids 
needed to ensure long term stability of the formed synthetic cells, 
it highlights the potential of mimicking natural systems in their 
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ability to couple the replication of genetic information with struc-
tural and morphological changes to trigger cell division.[202]  
Figure 14. Schematic representation of the chemical link between (A) amplifi-
cation of DNA and (B) self-reproduction of GVs.[201] 
8. Summary and Outlook 
In this review, we have highlighted recent progress in the under-
standing of natural vesicles and current efforts to prepare in-
creasingly sophisticated synthetic vesicles. In recent years, our 
knowledge of the origin and different roles of natural vesicles 
has constantly increased. In the same fashion, we have im-
proved our understanding of membrane chemistry and physics, 
and how to manipulate these to control membrane properties, 
including membrane asymmetry, binding and fusion at the 
membrane, or vesicle compartmentalization. The parallel pro-
gress in these two areas is now starting to converge, in a man-
ner that synthetic systems that were developed following na-
ture’s inspiration are now valuable tools to increase our under-
standing of natural systems. Therefore, it is not surprising that 
more and more often researchers are reporting new sophisticat-
ed synthetic vesicular systems that can deliver an impact in 
biological systems, through the controlled (co)administration of 
drugs, or functioning as synthetic organelles to repair damaged 
cellular function. This feedback between the fields of natural and 
synthetic vesicles will open up the path to finally develop appli-
cations that were not possible otherwise and eventually replicate 
and harness the sophisticated functioning of natural cells. 
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While we further our understanding of 
the biological properties of vesicles 
and their physiological functions, 
increasingly elegantly artificial vesicles 
are being reported for a wide range of 
technological applications and basic 
studies. Herein, we bring together 
both the biological and synthetic state-
of-the-art on vesicles and place their 
biological features in the context of 
recent synthetic developments, 
providing a unique view of these com-
plex and rapidly developing fields.  
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